1 GPC
1 GPC
1 GPC
Special bacteriology
Bacterial taxonomy
Domeniul
Tipul
Clasa
Ordinul
Familia
Genul
Specia
Classification according to Gram staining
• Gram-positive cocci
• Gram-negative cocci
• Gram-positive rods
• Gram-negative rods and coccobacilli
• Bacteria not stained by Gram
– acid and alcohol resistant bacteria
– cell wall lacking bacteria
– spirochaetes
– strictly intracellular bacteria
3
Gram-positive cocci
Staphylococci and related Gram-positive
cocci (GPC)
= catalase-positive GPC
Staphylococcus genus
• Gram-positive spherical cells
• arranged in grape-like irregular clusters (staphylos =
grape)
• several species (more than 40)
6
Habitat
• some staphylococcal species are named after the site they colonize:
– S. auricularis
– S. capitis
7
Classification
according to the production of free coagulase:
– coagulase-positive staphylococci
• S. aureus
• S. hyicus-intermedius group
– coagulase-negative staphylococci (CNS) -
• S. epidermidis group
– S. epidermidis
– S. haemolyticus
– S. hominis
– S. capitis
– S. caprae
• S. saprophyticus group
– S. saprophyticus
– S. xylosus
– S. lentus
• S. simulans group
• S. lugdunensis
8
Morphology
• spherical
• size: 0,8-1 µm
• no flagella, no spores
• capsule may be present
9
Staphylococcus spp.- Gram
stain
• Gram-positive
cocci:
– in clusters
– isolated cocci
– diplococci
– short chains
10
Cultivation
11
Colony morphology
12
Staphylococcus spp. on blood agar plate - β
haemolysis
13
Pigmented S colonies
14
Pigment production +/-
15
Biochemical properties
• in case of medically important staphylococcal species free coagulase is produced only by S. aureus
16
Staphylococcus aureus
• most important species
• major pathogen for humans
• may be present as a colonizer - healthy carrier status
– typical sites of S. aureus colonization:
• anterior nares – reservoir in humans
• pharyngeal mucosa
• skin (axillary, perineal, groin region)
• carrier rate: 10-40%
17
Pathogenesis
• Portal of entry
– skin lesions (including surgical wounds), hair follicles
– gastrointestinal tract
– respiratory tract
– vaginal mucosa
18
Virulence factors
• Surface proteins
– clumping factor
• adherence of the organism to fibrinogen and fibrin (endocoagulase)
• when mixed with plasma on a slide, S. aureus forms clumps
• Enzymes
– Coagulase, fibrinolysin
– Hyaluronidase
– DN-ase
– Lipolytic enzymes
– others
19
Factors that inhibit phagocytosis
• Microcapsule
• Protein A
– binds to the Fc portion of IgG molecules
– role in the diagnosis of S. aureus
– spa – gene encoding protein A – molecular typing
• Leukocidin
• Coagulase – forms a fibrin coat around the infectious focus that stop
phagocytic cells
• Clumping factor: masks surface antigens
20
Exotoxins
• α-, β-, γ-, δ-toxins (haemolysins) – lysis of erythrocytes through pore
formation on their membranes
• leukocidins – destroy leukocytes (e.g. Panton-Valentin leucocidin - PVL)
• superantigens: non-specifically activate large numbers of T-cells → large
amounts of cytokins are released
– toxic shock syndrome toxin (TSST-1)
– enterotoxins (A-E, G-I, K-M) – heat-stable
– exfoliative toxins A, B – epidermolytic toxins (separation of the epidermis at the granular
cell layer)
21
Types of infections:
• localized infections
• systemic infections
• toxic syndromes
22
Diseases
Typical pyogenic infections: skin infections such as furuncle or other localized
abscesses (focal suppurations), hair follicle infection
- localized, painful inflammatory reaction
23
Furuncle (boil)
Carbuncle
Diseases
– impetigo – skin disease
Other infections caused by
S. aureus
• other soft tissue infections – mastitis, wound infections (most frequent cause
of surgical site infections)
• osteomyelitis - leading to necrosis of the bone and chronic suppuration
• arthritis
• pneumonia – HCAI, especially in ventilated patients
• sinusitis, otitis, mastoiditis
• meningitis
Generalized diseases
• from any one infection focus organisms may spread via
the lymphatics and bloodstream to other parts of the body
– endocarditis
– sepsis – secondary suppurative foci in any organ = metastatic
abscesses with the typical signs of the affected organ
Toxin-mediated staphylococcal diseases - 1
• Food poisoning – due to enterotoxin producing strains (growing in
carbohydrate and protein foods)
– enterotoxin: heat-resistant (not inactivated by short cooking)
– short incubation period
– violent nausea, vomiting and diarrhea
– rapid convalescence
– no fever
Toxin-mediated staphylococcal diseases - 2
• Toxic shock syndrome (due
to TSST)
– toxic shock: fever,
hypotension, diffuse rash
(desquamate), involvement of
liver, kidneys, central nervous
system, blood, etc.
• tampon-using menstruating
women
• wound infections
• nasal packing used to stop
bleeding from the nose
Toxin-mediated staphylococcal diseases - 3
• Scalded skin syndrome – exfoliative toxin
– fever, large bullae, serous fluid exudes, electrolyte imbalance
– young children
Nosocomial infections
32
Emerging MRSA strains:
community-acquired MRSA (CA-
MRSA)
• different genetic background
• higher virulence, better bacterial fitness
• PVL production – necrotizing pneumonia
• children, young adults may be affected (serious, life-threatening infections)
Immunity in staphylococcal
diseases
• there is no long-lasting immunity
• reinfection is possible
34
Epidemiology
35
Prevention
• no vaccine
• hand hygiene, aseptic management of lesions
• high risk areas in hospitals:
– newborn nursery
– operating rooms
– intensive care units
– cancer chemotherapy wards
• high-risk patient and personnel screening
• isolation policies – infection control policies,
• “search and destroy” policy: newly admitted patients are quarantined until MRSA colonization
is excluded
– for this approach to be efficient:
• rapid diagnostic methods are to be used (PCR)
• low prevalence of MRSA
36
Prevention
• screening for S. aureus colonization
– in patients for whom surgical interventions (mainly in orthopedics, thoracic
surgery) are planned
– in close communities in epidemiological context
38
Diagnosis
• rapid diagnosis of MRSA
– polymerase chain reaction based methods (results in a few
hours), chromogenic agar media
• conventional bacteriology:
– cultivation
– identification
39
Coagulase-negative staphylococci (CNS)
41
S. saprophyticus
• inhabits the skin surrounding the genitourinary tract
• young women – acute cystitis (honeymoon cystitis)
• strong adhesion
• intense urease production: NH3 release, irritation - painful
• exoprotein (haematuria – presence of blood in urine)
• diagnosis: novobiocin resistance
42
Diagnosis of staphylococcal infections
Streptococci, enterococci and
streptococcus-like bacteria
Catalase negative group of Gram-positive
cocci
Streptococcus genus
Streptococcus genus
• Gram-positive cocci in chains
• streptos=chain
• large and heterogeneous group of bacteria
• widely distributed in nature
– some are member of the normal flora
– others are associated with important human diseases
• due to infection with them
• due to sensitization to them
• Aerobic, facultative anaerobic (some species favor
microaerophilic conditions)
• some species are strictly anaerobic
47
Classification
• according to group-specific C carbohydrate contained in the cell wall
(Lancefield classification)
– A-U
• medically important groups:
– group A streptococci (GAS) – Streptococcus pyogenes
– group B streptococci (GBS) – Streptococcus agalactiae
– group C, G streptococci (Streptococcus dysgalactiae and others)
– group D streptococci (Streptococcus bovis, Streptococcus gallolyticus)
• according to hemolysis
– β-hemolysis (GAS, GBS, GCS, GGC)
– α-hemolysis (Streptococcus pneumoniae, viridans streptococci)
– non-hemolytic streptococci (Streptococcus group D)
Morphology
• spherical or oval
• Size: 1 µm
• no flagella
• no spores
• capsule (S. pneumoniae -
polysaccharide, S. pyogenes –
hyaluronic acid)
49
Cultivation
50
Biochemical properties
• catalase negative
• ferment different sugars
• resistant to bile (exception: S. pneumoniae)
51
Antigenic structure
• C carbohydrate
– group specific
– Lancefield classification – precipitation or agglutination reaction
– diagnostic importance
• M protein
– type-specific
– GAS: includes 80 serotypes according to M protein
• protective antibodies are formed against M protein
– important virulence factor
52
S. pyogenes (group A
streptococci)
• susceptible to bacitracin – specific to A group
• M protein – over 200 serotypes
– in certain diseases certain serotypes are predominant
• rheumatogenic
• nephritogenic
53
Streptococcus pyogenes
Both the infectious and carrier state may lead to transmission, dominated by the infectious state.
A few studies have reported Strep A transmission from carriers to uninfected individuals who have
subsequently become symptomatic.
57
Virulence factors: toxins
• erythrogenic toxin (superantigen)
– rash – scarlet fever
– produced only by certain strains lysogenized by a phage containing the gene of the toxin
– antigenic – antibodies are protective
• streptolysin O (SLO)
– oxygen-labile hemolysin
– antigenic; antibodies: ASLO – diagnostic importance
• streptolysin S
– oxygen-stable
– not antigenic; responsible for hemolysis on blood agar plate
• pyrogenic exotoxin A - streptococcal toxic shock syndrome
• exotoxin B: preotease – involved in the pathogenesis of necrotizing fasciitis
Virulence factors – surface proteins
• M protein - gives the streptococcus the ability to resist phagocytosis by polymorphonuclear leukocytes
in the absence of type-specific antibodies
The appearance of the M molecule on the surface of the streptococcal cell wall.
Feretti JJ et al: Streptococcus pyogenes Basic Biology to
Clinical Manifestations, 2017
Virulence factors – pili
• colonization of human tissues
Strawberry tongue
Diseases – according to portal of entry
• Genital infections
– endometritis and sepsis after delivery
Streptococcal diseases
• immunological response
• acute glomerulonephritis
• acute rheumatic fever
Acute glomerulonephritis
• usually after skin infections
• symptoms
– hypertension
– edema of the face and ankle
• symptoms:
– fever
– painful migratory polyarthritis
– carditis (myocardial and endocardial tissue are damaged –
mitral and aortic valve)
– chorea (uncontrollable movement of limbs)
• antitoxic immunity
– TSS, erythrogenic toxin
76
Epidemiology
• loss of M proteins during long-term carriage: loss of virulence – no point for searching GAS
carriage (except close family members of a patient with rheumatic fever)
77
Treatment of streptococcal
infections
• Pharyngitis: wait for the lab result and treat only if positive! this way antibiotic overuse may
be prevented;
• Penicillin (10 days needed) – there is no documented resistance to penicillin
• Cephalosporins (5 days)
• In case of allergy: macrolides (susceptibility should be tested)
78
Diagnosis
79
S. agalactiae (group B
streptococcus)
• Morphology same as for GAS
• Colonies are larger, grayish, surrounded by hemolysis
• positive CAMP test
• virulence factors
– M protein
– Lipoteichoic acid
– hemolysin
80
GBS
• Found in digestive tract and vagina (35% of women are carriers)
• Diseases during pregnancy
– abortion
– early membrane rupture
– Intrauterine infection
– puerperal fever
• Diseases of the neonate
– early onset sepsis, meningitis
– late onset sepsis
• Diagnosis
– cultivation – in case of infection
• Prevention
– screening of pregnant women – 36th gestational week (do not treat colonized women!) – give
penicillin or ampicillin prophylaxis during delivery to prevent neonatal infection
• Treatment of established infections: penicillin
81
Group D streptococci
• bovis group, includes Streptococcus gallolyticus (involved in sepsis,
endocarditis – patients developing systemic infections should be searched for
colon cancer)
S. pneumoniae
• Morphology
– Gram-positive diplococci, chains
– lance shaped cocci
– Capsule – (mainly in vivo)
• Cultivation
– Blood agar plate – 1-3 mm colonies (S, R, M)
– α hemolysis
• Identification
– susceptible to optochin, bile
83
Streptococcus pneumoniae
LL 84
Streptococcus pneumoniae
- immunofluorescent assay
85
Sputum – Gram stain
86
Sputum – Gram stain
staphylococci
pneumococci
2005 LL 87
Neufeld reaction – quellung
reaction (antigen-antibody
reaction)
88
Susceptibility to optochin
2005 LL 89
• Antigenic structure
– capsule: type specific polysaccharide
– over 85 serotypes
• Virulence factors
– Capsule – antiphagocytic, several serotypes defined according to
its structure
– Neuraminidase – toxic effect
– Pneumolysin - hemolyzin, cytotoxic
– Hyaluronidase
90
Diseases
• present in the normal flora - 50-70% of population (IgA production enables colonization of the
upper respiratory tract mucosa)
91
Streptococcus pneumoniae
• Prevention
– Polysaccharide vaccine – for adults (includes 7 or 23 serotypes)
• People older than 65 years
• Smokers
• Chronic underlying diseases
– Conjugate vaccines – for children
• (antigen + diphtheria toxoid)
• heptavalent (7), decavalent (10), triskaivalent (13)
– Herd effect!
92
S. pneumoniae
• Treatment
– susceptibility to antibiotics must be tested
– decreased susceptibility to penicillin or even resistance may occur
• Diagnosis
– rapid diagnosis:
• detection of pneumococcal antigens from sputum, urine, LCR
• detection of nucleic acid from sputum
– conventional methods: cultivation, identification
Viridans streptococci –
oropharyngeal streptococci
• Facultative/strict anaerobic
• α hemolysis
• Groups:
– group anginosus (S. anginosus, S. constellatus, S. intermedius)
– group mitis (S. mitis, S. oralis, S. sanguinis, S. gordonii and others)
– group salivarius (S. salivarius, S. vestibularis)
– goup mutans (S. mutans, S. sobrinus)
94
Group anginosus
• involved in purulent lesions, deep abscesses of abdominal or oral origin, endocarditis
• cultures have a peculiar caramel smell
• S. anginosus, S. constellatus, S. intermedius
• most anginosus group isolates belong to the non-β-hemolytic oral streptococci, but β-
hemolytic strains are found in all 3 species.
• Some anginosus group strains carry a typeable Lancefield group antigen, which belongs to
group F, C, G, or A!
Streptococcus mutans
96
Streptococcus mutans
2005 LL 97
Enterococcus genus
• normal flora of the gastrointestinal tract
• blood agar plate: grayish colonies
• α hemolysis +/-
• resistant to bile, decompose esculine
• low virulence
• high nosocomial potential
• difficult to treat infections – due to natural
resistance against several antibiotics
98
• Diseases
– urinary tract infections
– gallbladder infections
– wound infections
– bacteraemia – may indicate colon cancer
– endocarditis
• Diagnosis
– conventional methods are not enough for relible diagnosis and species level identification
• Treatment
– intrinsic resistance to cephalosporins, clindamycin, SXT + low-level resistance against
aminoglycosides (if high level resistance is excluded, gentamicin or streptomycin can be used
in association with other active antibiotics for their synergistic effect)
99
Streptococcus-like bacteria
• Abiotrophia and Granulicatella
– “nutritionally variant streptococci”
– thiol-requiring, pyridoxal-requiring, and
“satelliting” streptococci, staphylococci or enteric
rods
– part of human microbiome
– occasionally involved in infections: sepsis,
endocarditis, CNS infections, early-onset
neonatal, ocular, lung infections…
– difficult to culture – cystein containing media can
support their growth
– more resistant than viridans group streptococci
– MIC is needed for AST
Streptococcus-like bacteria
• Aerococcus spp
– found in the environment, including air, dust, soil, vegetation, meat products, and the hospital
environment
– can easily be confused with the viridans streptococci and enterococci
– tend to form tetrads when grown in broth
– Aerococcus urinae may colonize urinary tract – or cause infections (urinary and others)
• standardization in EUCAST
• Leuconostoc spp.
– use in the dairy and pickling industries and in wine making
– found in fermented sausages, vacuum-packed meat products, cereals, and dairy products (butter,
cream, fresh/raw milk, cheese)
– intrinsically resistant to vancomycin
– Leuconostoc bacteremia has been documented predominantly in patients with underlying malignancies
(acute myeloid leukemia, non-Hodgkin’s lymphoma, hepatocellular carcinoma) and as a complication
of solid-organ (e.g., liver) and stemcell transplantation.
Streptococcus-like bacteria
• Pediococcus spp.
– may be found in beers and ales and are also used in foods for processing and preservation
– flavor enhancers in processed vegetables and soy products and are used in biotechnology
as indicator strains for vitamin bioassays
– may be isolated from various human clinical specimens, including stool, urine, wounds,
abscesses, and blood cultures.
– usually there are some underlying conditions - hematologic malignancies, cardiovascular
disease, chronic lung disease, pancreatitis, and diabetes
– previous abdominal surgery or nasogastric tubes or central venous catheters for total
parenteral nutrition in place for prolonged periods
– intrinsically resistant to vancomycin
Streptococcus-like bacteria
• Gemella spp.
– characteristically appears as diplococci with
adjacent sides flattened, easily destained GPC
– Gemella species are infrequently isolated from
clinical specimens. Cultural similarity to viridans
streptococci has likely resulted in misidentifications
– G. haemolysans is part of the upper respiratory tract
flora, whereas G. morbillorum is found in the
respiratory and gastrointestinal tracts. Both
organisms have been isolated as occasional
causes of bacteremia and endocarditis involving
both native and prosthetic heart valves in pediatric
and adult patients
Streptococcus-like bacteria
• Vagococcus spp. • Globicatella sanguinis
– motile Gram-positive cocci – animal species – =short chain composed of spherical cells
– Only V. fluvialis has been isolated from clinical – endocarditis, UTI and other infections (rarely
specimens obtained from humans. isolated)
• Alloiococcus spp.
– A. otitis – middle ear infections - middle ear
aspirates submitted for culture should be
incubated under microaerophilic conditions for at
least 5 days to facilitate detection of these
bacteria
– might be also isolated from blood, sputum